This article must adhere to the biographies of living persons (BLP) policy, even if it is not a biography, because it contains material about living persons. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libellous. If such material is repeatedly inserted, or if you have other concerns, please report the issue to this noticeboard.If you are a subject of this article, or acting on behalf of one, and you need help, please see this help page. |
![]() | This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||
|
![]() | The Wikimedia Foundation's Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see WP:PAID. For advice about reviewing paid contributions, see WP:COIRESPONSE. Edits made by the below user(s) were last checked for neutrality on 31-12-2016 by Example.
|
![]() | Individuals with a conflict of interest, particularly those representing the subject of the article, are strongly advised not to directly edit the article. See Wikipedia:Conflict of interest. You may request corrections or suggest content here on the Talk page for independent editors to review, or contact us if the issue is urgent. |
requested edit
editMy name is Florian Schaub at Merck KGaA. My aim is to make some changes in this article, because we have identified some misleading information. I have provided clearly arranged suggestions that you can see below on the talk page. They all follow the same pattern: • Current Version • Suggested Revision (Suggested changes are bold) • Reason • Suggested Reference (if needed) Please let me know if anyone has concerns.
Current Version Oschmann is the vice president of the European Federation of Pharmaceutical Industries and Associations (EFPIA).
Suggested Revision (Suggested changes are bold) Oschmann is the president of the European Federation of Pharmaceutical Industries and Associations (EFPIA) since June 14, 2017.
Reason This is an important information for the other roles of Stefan Oschmann.
Suggested Reference (if needed) http://www.chemanager-online.com/news-opinions/nachrichten/efpia-stefan-oschmann-zum-praesidenten-gewaehlt
--Florian Schaub at Merck KGaA (talk) 15:57, 19 June 2017 (UTC)
- done. Jytdog (talk) 00:32, 20 June 2017 (UTC)